Molecular Templates Inc MTEM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/24/22 EDT
1.05quote price arrow down-0.01 (-0.94%)
Volume
254,301
Close
1.06quote price arrow up+0.11 (+11.58%)
Volume
4,391,181
52 week range
0.76 - 8.62
Loading...
  • Open1.00
  • Day High1.19
  • Day Low1.00
  • Prev Close1.06
  • 52 Week High8.62
  • 52 Week High Date06/28/21
  • 52 Week Low0.76
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap59.72M
  • Shares Out56.34M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta1.53
  • YTD % Change-72.96

KEY STATS

  • Open1.00
  • Day High1.19
  • Day Low1.00
  • Prev Close1.06
  • 52 Week High8.62
  • 52 Week High Date06/28/21
  • 52 Week Low0.76
  • 52 Week Low Date06/16/22
  • Market Cap59.72M
  • Shares Out56.34M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta1.53
  • YTD % Change-72.96

RATIOS/PROFITABILITY

  • EPS (TTM)-1.38
  • P/E (TTM)-0.77
  • Fwd P/E (NTM)-0.59
  • EBITDA (TTM)-67.383M
  • ROE (TTM)-99.90%
  • Revenue (TTM)43.96M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-177.06%
  • Debt To Equity (MRQ)75.26%

EVENTS

  • Earnings Date08/10/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Molecular Templates Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Molecular Templates, Inc. is a clinical stage biopharmaceutical company that is focused on the discovery and development of differentiated, targeted, biologic therapeutics for cancer and other serious diseases. The Company utilizes its biologic drug platform to design and generate engineered toxin bodies (ETBs). ETBs use a genetically engineered version of the Shiga-like Toxin A subunit (SLTA), a ribosome inactivating bacterial protein. The Company is developing ETBs for...
Harold Selick Ph.D.
Independent Chairman of the Board
Eric Poma Ph.D.
Chief Executive Officer, Chief Scientific Officer, Director
Jason Kim
President, Chief Operating Officer
Sean McLennan
Interim Chief Financial Officer, Senior Vice President - Finance, Principal Accounting Officer, Corporate Controller, Treasurer
Megan Filoon
General Counsel
Address
9301 Amberglen Blvd Ste 100
Austin, TX
78729-1153
United States

Top Peers

SYMBOLLASTCHG%CHG
PLX
Protalix Biotherapeutics Inc
1.10-0.01-0.91%
ORGS
Orgenesis Inc
2.52+0.13+5.44%
ANGN
Angion Biomedica Corp
1.96-0.01-0.51%
CDTX
Cidara Therapeutics Inc
0.52-0.0349-6.2894%
SYRS
Syros Pharmaceuticals Inc
0.8914-0.1286-12.6078%